Couvineau A, Amiranoff B, Laburthe M
J Biol Chem. 1986 Nov 5;261(31):14482-9.
Vasoactive intestinal peptide (VIP) receptors were solubilized using the nondenaturing detergent Triton X-100 after occupancy of rat liver membrane-bound receptors with 125I-VIP. Gel filtration and ultracentrifugation on sucrose density gradients revealed the existence in the soluble macromolecular fraction of two labeled components: a major (80%) heavy component and a minor (20%) light one. The two components exhibit the following hydrodynamic parameters: Stokes radius, 5.8 nm: s20,w, 5.98 s; Mr, 150,000; frictional ratio, 1.52 for the major; and Stokes radius, 3.0 nm: s20,w, 3.98 s; Mr = 52,000; frictional ratio, 1.12 for the minor component. The labeling of these components was specific in that it dramatically decreased when unlabeled VIP was added together with 125I-VIP. The pharmacological specificity was also assessed by using 10 nM histidylisoleucineamide (a VIP agonist). Many lines of evidence indicate that the light component (Mr = 52,000) is the VIP-receptor complex while the heavy component (Mr = 150,000) is a ternary complex consisting of VIP, the receptor, and a guanine nucleotide regulatory protein, probably Ns. GTP is required to dissociate 125I-VIP from the heavy component whereas it is ineffective on the light component. This effect is nucleotide specific. After cholera toxin-induced [32P]ADP ribosylation of liver membranes, a high peak of 32P radioactivity containing the alpha subunit (Mr = 42,000) of the Ns protein is coeluted with the heavy component on Sephacryl S-300. By mild urea (2 M) treatment, the heavy component is converted into the light without significant dissociation of 125I-VIP. When a Triton extract of membranes prelabeled with 125I-VIP is treated with dithiobis(succinimidyl propionate) subsequent sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis reveals a major band corresponding to Mr = 150,000. Alternatively, when prelabeled membranes are directly treated with the cross-linker, a major complex of Mr = 51,000 is observed. This may be related to different accessibility of the cross-linker to the site at which the receptor and the Ns protein interact in the two conditions. In conclusion, these data represent initial reports on the successful solubilization of functional VIP-receptor complexes and provide evidence for an interaction between liver VIP-receptor complexes and a GTP-binding protein.
用非变性去污剂 Triton X-100 使血管活性肠肽(VIP)受体溶解,此前用 125I-VIP 占据大鼠肝细胞膜结合受体。凝胶过滤和蔗糖密度梯度超速离心显示,在可溶性大分子部分存在两种标记成分:一种主要的(80%)重成分和一种次要的(20%)轻成分。这两种成分具有以下流体动力学参数:主要成分的斯托克斯半径为 5.8 nm,沉降系数 s20,w 为 5.98 s,相对分子质量 Mr 为 150,000,摩擦比为 1.52;次要成分的斯托克斯半径为 3.0 nm,沉降系数 s20,w 为 3.98 s,Mr = 52,000,摩擦比为 1.12。这些成分的标记具有特异性,因为当未标记的 VIP 与 125I-VIP 一起添加时,标记显著减少。还使用 10 nM 组氨酰异亮氨酸酰胺(一种 VIP 激动剂)评估了药理学特异性。许多证据表明,轻成分(Mr = 52,000)是 VIP 受体复合物,而重成分(Mr = 150,000)是由 VIP、受体和鸟嘌呤核苷酸调节蛋白(可能是 Ns)组成的三元复合物。从重组分中解离 125I-VIP 需要 GTP,而对轻成分无效。这种作用是核苷酸特异性的。在霍乱毒素诱导肝细胞膜的[32P]ADP 核糖基化后,含有 Ns 蛋白α亚基(Mr = 42,000)的 32P 放射性高峰与重成分在 Sephacryl S-300 上共洗脱。通过温和的尿素(2 M)处理,重组分转化为轻组分,而 125I-VIP 没有明显解离。当用二硫代双(琥珀酰亚胺丙酸酯)处理预先用 125I-VIP 标记的膜的 Triton 提取物,随后进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析时,显示出一条对应于 Mr = 150,000 的主要条带。或者,当预先标记的膜直接用交联剂处理时,观察到一个 Mr = 51,000 的主要复合物。这可能与两种条件下交联剂对受体和 Ns 蛋白相互作用位点的不同可及性有关。总之,这些数据代表了关于成功溶解功能性 VIP 受体复合物的初步报告,并为肝 VIP 受体复合物与 GTP 结合蛋白之间的相互作用提供了证据。